Skin cancer is one of the most common types of cancer around the world. For this reason, over the past years, different approaches have been proposed to assist detect it. Nonetheless, most of them are based only on dermoscopy images and do not take into account the patient clinical information. In this work, first, we present a new dataset that contains clinical images, acquired from smartphones, and patient clinical information of the skin lesions. Next, we introduce a straightforward approach to combine the clinical data and the images using different well-known deep learning models. These models are applied to the presented dataset using only the images and combining them with the patient clinical information. We present a comprehensive study to show the impact of the clinical data on the final predictions. The results obtained by combining both sets of information show a general improvement of around 7% in the balanced accuracy for all models. In addition, the statistical test indicates significant differences between the models with and without considering both data. The improvement achieved shows the potential of using patient clinical information in skin cancer detection and indicates that this piece of information is important to leverage skin cancer detection systems.
Convolutional Neural Networks (CNNs) have been used for automated detection of prostate cancer where Area Under Receiver Operating Characteristic (ROC) curve (AUC) is usually used as the performance metric. Given that AUC is not differentiable, common practice is to train the CNN using a loss functions based on other performance metrics such as cross entropy and monitoring AUC to select the best model. In this work, we propose to fine-tune a trained CNN for prostate cancer detection using a Genetic Algorithm to achieve a higher AUC. Our dataset contained 6-channel Diffusion-Weighted MRI slices of prostate. On a cohort of 2,955 training, 1,417 validation, and 1,334 test slices, we reached test AUC of 0.773; a 9.3% improvement compared to the base CNN model.
X-ray examination is suitable for screening of gastric cancer. Compared to endoscopy, which can only be performed by doctors, X-ray imaging can also be performed by radiographers, and thus, can treat more patients. However, the diagnostic accuracy of gastric radiographs is as low as 85%. To address this problem, highly accurate and quantitative automated diagnosis using machine learning needs to be performed. This paper proposes a diagnostic support method for detecting gastric cancer sites from X-ray images with high accuracy. The two new technical proposal of the method are (1) stochastic functional gastric image augmentation (sfGAIA), and (2) hard boundary box training (HBBT). The former is a probabilistic enhancement of gastric folds in X-ray images based on medical knowledge, whereas the latter is a recursive retraining technique to reduce false positives. We use 4,724 gastric radiographs of 145 patients in clinical practice and evaluate the cancer detection performance of the method in a patient-based five-group cross-validation. The proposed sfGAIA and HBBT significantly enhance the performance of the EfficientDet-D7 network by 5.9% in terms of the F1-score, and our screening method reaches a practical screening capability for gastric cancer (F1: 57.8%, recall: 90.2%, precision: 42.5%).
Deep learning object detection algorithm has been widely used in medical image analysis. Currently all the object detection tasks are based on the data annotated with object classes and their bounding boxes. On the other hand, medical images such as mammography usually contain normal regions or objects that are similar to the lesion region, and may be misclassified in the testing stage if they are not taken care of. In this paper, we address such problem by introducing a novel top likelihood loss together with a new sampling procedure to select and train the suspected target regions, as well as proposing a similarity loss to further identify suspected targets from targets. Mean average precision (mAP) according to the predicted targets and specificity, sensitivity, accuracy, AUC values according to classification of patients are adopted for performance comparisons. We firstly test our proposed method on a private dense mammogram dataset. Results show that our proposed method greatly reduce the false positive rate and the specificity is increased by 0.25 on detecting mass type cancer. It is worth mention that dense breast typically has a higher risk for developing breast cancers and also are harder for cancer detection in diagnosis, and our method outperforms a reported result from performance of radiologists. Our method is also validated on the public Digital Database for Screening Mammography (DDSM) dataset, brings significant improvement on mass type cancer detection and outperforms the most state-of-the-art work.
Non-invasive prostate cancer detection from MRI has the potential to revolutionize patient care by providing early detection of clinically-significant disease (ISUP grade group >= 2), but has thus far shown limited positive predictive value. To address this, we present an MRI-based deep learning method for predicting clinically significant prostate cancer applicable to a patient population with subsequent ground truth biopsy results ranging from benign pathology to ISUP grade group~5. Specifically, we demonstrate that mixed supervision via diverse histopathological ground truth improves classification performance despite the cost of reduced concordance with image-based segmentation. That is, where prior approaches have utilized pathology results as ground truth derived from targeted biopsies and whole-mount prostatectomy to strongly supervise the localization of clinically significant cancer, our approach also utilizes weak supervision signals extracted from nontargeted systematic biopsies with regional localization to improve overall performance. Our key innovation is performing regression by distribution rather than simply by value, enabling use of additional pathology findings traditionally ignored by deep learning strategies. We evaluated our model on a dataset of 973 (testing n=160) multi-parametric prostate MRI exams collected at UCSF from 2015-2018 followed by MRI/ultrasound fusion (targeted) biopsy and systematic (nontargeted) biopsy of the prostate gland, demonstrating that deep networks trained with mixed supervision of histopathology can significantly exceed the performance of the Prostate Imaging-Reporting and Data System (PI-RADS) clinical standard for prostate MRI interpretation.
Accurate and efficient detection of ovarian cancer at early stages is critical to ensure proper treatments for patients. Among the first-line modalities investigated in studies of early diagnosis are features distilled from protein mass spectra. This method, however, considers only a specific subset of spectral responses and ignores the interplay among protein expression levels, which can also contain diagnostic information. We propose a new modality that automatically searches protein mass spectra for discriminatory features by considering the self-similar nature of the spectra. Self-similarity is assessed by taking a wavelet decomposition of protein mass spectra and estimating the rate of level-wise decay in the energies of the resulting wavelet coefficients. Level-wise energies are estimated in a robust manner using distance variance, and rates are estimated locally via a rolling window approach. This results in a collection of rates that can be used to characterize the interplay among proteins, which can be indicative of cancer presence. Discriminatory descriptors are then selected from these evolutionary rates and used as classifying features. The proposed wavelet-based features are used in conjunction with features proposed in the existing literature for early stage diagnosis of ovarian cancer using two datasets published by the American National Cancer Institute. Including the wavelet-based features from the new modality results in improvements in diagnostic performance for early-stage ovarian cancer detection. This demonstrates the ability of the proposed modality to characterize new ovarian cancer diagnostic information.
Medical imaging is the most important tool for detecting complications in the inner body of medicine. Nowadays, with the development of image processing technology as well as changing the size of photos to higher resolution images in the field of digital medical imaging, there is an efficient and accurate system for segmenting this. Real-world images that for a variety of reasons have poor heterogeneity, noise and contrast are essential. Digital image segmentation in medicine is used for diagnostic and therapeutic analysis, which is very helpful for physicians. In this study, we aim at liver cancer photographs, which aim to more accurately detect the lesion or tumor of the liver because accurate and timely detection of the tumor is very important in the survival and life of the patient.The aim of this paper is to simplify the obnoxious study problems related to the study of MR images. The liver is the second organ most generic involved by metastatic disease being liver cancer one of the prominent causes of death worldwide. Without healthy liver a person cannot survive. It is life threatening disease which is very challenging perceptible for both medical and engineering technologists. Medical image processing is used as a non-invasive method to detect tumours. The chances of survival having liver Tumor highly depends on early detection of Tumor and then classification as cancerous and noncancerous tumours. Image processing techniques for automatic detection of brain are includes pre-processing and enhancement, image segmentation, classification and volume calculation, Poly techniques have been developed for the detection of liver Tumor and different liver toM oR detection algorithms and methodologies utilized for Tumor diagnosis. Novel methodology for the detection and diagnosis of liver Tumor.
Skin cancer is a major public health problem around the world. Its early detection is very important to increase patient prognostics. However, the lack of qualified professionals and medical instruments are significant issues in this field. In this context, over the past few years, deep learning models applied to automated skin cancer detection have become a trend. In this paper, we present an overview of the recent advances reported in this field as well as a discussion about the challenges and opportunities for improvement in the current models. In addition, we also present some important aspects regarding the use of these models in smartphones and indicate future directions we believe the field will take.
Lung cancer is a leading cause of cancer-related deaths worldwide, and early detection is crucial for improving patient outcomes. Nevertheless, early diagnosis of cancer is a major challenge, particularly in low-resource settings where access to medical resources and trained radiologists is limited. The objective of this study is to propose an automated end-to-end deep learning-based framework for the early detection and classification of lung nodules, specifically for low-resource settings. The proposed framework consists of three stages: lung segmentation using a modified 3D U-Net named 3D Res-U-Net, nodule detection using YOLO-v5, and classification with a Vision Transformer-based architecture. We evaluated the proposed framework on a publicly available dataset, LUNA16. The proposed framework's performance was measured using the respective domain's evaluation matrices. The proposed framework achieved a 98.82% lung segmentation dice score while detecting the lung nodule with 0.76 mAP@50 from the segmented lung, at a low false-positive rate. The performance of both networks of the proposed framework was compared with other studies and found to outperform them regarding segmentation and detection accuracy. Additionally, our proposed Vision transformer network obtained an accuracy of 93.57%, which is 1.21 higher than the state-of-the-art networks. Our proposed end-to-end deep learning-based framework can effectively segment lungs, and detect and classify lung nodules, specifically in low-resource settings with limited access to radiologists. The proposed framework outperforms existing studies regarding all the respective evaluation metrics. The proposed framework can potentially improve the accuracy and efficiency of lung cancer screening in low-resource settings, ultimately leading to better patient outcomes.
Prostate cancer is one of the most common forms of cancer and the third leading cause of cancer death in North America. As an integrated part of computer-aided detection (CAD) tools, diffusion-weighted magnetic resonance imaging (DWI) has been intensively studied for accurate detection of prostate cancer. With deep convolutional neural networks (CNNs) significant success in computer vision tasks such as object detection and segmentation, different CNNs architectures are increasingly investigated in medical imaging research community as promising solutions for designing more accurate CAD tools for cancer detection. In this work, we developed and implemented an automated CNNs-based pipeline for detection of clinically significant prostate cancer (PCa) for a given axial DWI image and for each patient. DWI images of 427 patients were used as the dataset, which contained 175 patients with PCa and 252 healthy patients. To measure the performance of the proposed pipeline, a test set of 108 (out of 427) patients were set aside and not used in the training phase. The proposed pipeline achieved area under the receiver operating characteristic curve (AUC) of 0.87 (95% Confidence Interval (CI): 0.84-0.90) and 0.84 (95% CI: 0.76-0.91) at slice level and patient level, respectively.